Off-label use of thalidomide for the treatment of a bleeding cutaneous metastasis

Submitted: 7 December 2014
Accepted: 22 January 2015
Published: 5 October 2015
Abstract Views: 1138
PDF: 770
HTML: 385
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

We herein describe the case of a 65-year-old man with frequent hospitalizations for severe anemia due to several recurrent bleedings of a cutaneous metastasis of hepatocellular carcinoma, and its successful off label treatment with thalidomide therapy for controlling bleeding and reducing transfusion requirements.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Silvestri, F., Da Porto, A., Labombarda, A., Mansutti, E., & Rogato, A. (2015). Off-label use of thalidomide for the treatment of a bleeding cutaneous metastasis. Italian Journal of Medicine, 9(4), 377–379. https://doi.org/10.4081/itjm.2015.570